European Union legislation on Health Technology Assessment – European Cancer Organisation
European Cancer Organisation shared a post on LinkedIn:
”A landmark piece of European Union legislation to achieve greater cooperation between countries on Health Technology Assessment (HTA) is due to come into force in January 2025, with cancer medicines among the first group of therapies in its focus. Is the EU ready for Joint Clinical Assessments? Have stakeholder views been taken account of? Is there still time to address any remaining concerns?
On Tuesday 8 October from 15:00-17:30 CEST, the 2024 ECO Community 365 Roundtable series will continue with a spotlight placed on the issue of ‘EU HTA Cooperation’.
Register and participate in the roundtable to be a part of the conversation.
The Roundtable will be co-chaired by Giuseppe Curigliano, ECO Board Member and President of the European Society of Breast Cancer Specialists and Natacha Bolaños, ECO Patient Advisory Committee Member and Regional Manager for Europe, Lymphoma Coalition.
More information will be published soon!”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023